Product Information
Name:
Revatropate
Synonyms:
- (3R-(3R*(S*(R*))))-1-Azabicyclo(2.2.2)oct-3-yl alpha-(hydroxymethyl)-alpha-(2-(methylsulfinyl)ethyl)benzenacetate
- (R)-3-Quinuclidinyl (S)-beta-hydroxy-alpha-(2-(R)-methylsulfinyl)ethyl)hydratropate
- Uk-112,166
- Unii-3W7L15V40W
- Benzenacetic acid, alpha-(hydroxymethyl)-alpha-(2-(methylsulfinyl)ethyl)-, 1-azabicyclo(2.2.2)oct-3-yl ester, (3R-(3R*(S*(R*))))-
- (3R)-1-azabicyclo[2.2.2]oct-3-yl (2S)-2-(hydroxymethyl)-4-[(R)-methylsulfinyl]-2-phenylbutanoate
Description:
Revatropate is a chiral compound that belongs to the class of antimuscarinic drugs. It is used to treat motility disorders such as constipation, diarrhea, and irritable bowel syndrome. Revatropate has been shown to have high activity against syncytial virus infections and inflammatory bowel disease. This drug also inhibits the synthesis of phospholipase A 2 , which has been implicated in the pathogenesis of autoimmune diseases. The molecular mechanism for this effect is not known, but it may be due to the inhibition of water vapor loss from the bladder by reducing ileal motility.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
365.49 g/mol
Formula:
C19H27NO4S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
